HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Riva Fineman Selected Research
Riva Fineman Research Topics
Disease
8
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 10/2014
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2019 - 05/2013
2
Neoplasms (Cancer)
09/2017 - 05/2013
1
Lymphoma (Lymphomas)
01/2022
1
Fever (Fevers)
01/2019
1
Neutropenia
01/2019
1
Hairy Cell Leukemia
01/2019
1
Residual Neoplasm
02/2018
1
Congenital Abnormalities (Deformity)
09/2017
1
Hematologic Neoplasms (Hematological Malignancy)
09/2017
1
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016
1
Nephrotic Syndrome (Syndrome, Nephrotic)
01/2016
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2014
1
Infections
12/2013
1
Sepsis (Septicemia)
05/2013
1
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2012
1
Cardiac Arrhythmias (Arrythmia)
12/2006
1
Sudden Death
12/2006
1
Cardiotoxicity
12/2006
1
Tumor Lysis Syndrome
01/2002
1
Philadelphia Chromosome
01/2002
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2002
Drug/Important Bio-Agent (IBA)
5
Rituximab (Mabthera)
FDA Link
01/2023 - 11/2014
4
fludarabine
IBA
01/2023 - 05/2015
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2023 - 05/2015
1
ibrutinib
IBA
01/2023
1
COVID-19 Vaccines
IBA
01/2022
1
BNT162 Vaccine
IBA
01/2022
1
Antibodies
IBA
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Immunoglobulin G (IgG)
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Vaccines
IBA
01/2022
1
obinutuzumab
IBA
01/2020
1
Chlorambucil (Leukeran)
FDA Link
01/2020
1
Cladribine
FDA Link
Generic
01/2019
1
purine
IBA
01/2019
1
Filgrastim (Neupogen)
FDA Link
01/2019
1
Dihydrotachysterol (AT 10)
IBA
05/2015
1
Anti-Bacterial Agents (Antibiotics)
IBA
12/2013
1
HLA Antigens (Human Leukocyte Antigens)
IBA
05/2013
1
Tyrosine Kinase Inhibitors
IBA
09/2012
1
Anthracyclines
IBA
12/2006
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2002
Therapy/Procedure
6
Therapeutics
01/2019 - 09/2012
4
Stem Cell Transplantation
10/2019 - 09/2012
2
Drug Therapy (Chemotherapy)
11/2014 - 05/2013
1
Injections
01/2022
1
Homologous Transplantation
09/2017
1
Hematopoietic Stem Cell Transplantation
01/2016